BioCentury | May 23, 2019
Company News

May 23 Company Quick Takes: Chiesi gains Raxone rights; plus WuXi Vaccines, a Zika first and more

...Other) Broad Institute of MIT and Harvard Chiesi Farmaceutici S.p.A. Columbia University Dynavax Technologies Corp. InBios International Inc. Regeneron Santhera Pharmaceuticals Holding AG Syntonix Pharmaceuticals Inc. TransCelerate...
BioCentury | Mar 7, 2016
Clinical News

Alprolix eftrenonacog alfa regulatory update

...BioCentury, Aug. 10, 2015). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
BioCentury | Sep 7, 2015
Clinical News

Long Acting rFactor lX: Interim Phase III data

...see BioCentury, Aug. 10). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
BioCentury | Aug 10, 2015
Company News

Syntonix, Biovitrum deal

...see BioCentury, June 29). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
...in 2007, and Biovitrum acquired Swedish Orphan International AB in 2009 and changed its name. Syntonix Pharmaceuticals Inc....
BioCentury | Dec 8, 2014
Company News

Syntonix, Biovitrum deal

...Nov. 10, 2014). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen Idec acquired Syntonix...
...in 2007, and Biovitrum acquired Swedish Orphan International AB in 2009 and changed its name. Syntonix Pharmaceuticals Inc....
BioCentury | Oct 20, 2014
Company News

Syntonix, Biovitrum deal

...between Swedish Orphan and Biogen Idec was between Biovitrum AB and Syntonix Pharmaceuticals Inc. Biogen Idec acquired Syntonix...
...products using XTEN to treat hemophilia (see BioCentury, April 18, 2011 & April 28, 2014). Syntonix Pharmaceuticals Inc....
BioCentury | Jul 28, 2014
Clinical News

Long Acting rFactor lX regulatory update

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....
BioCentury | Jul 14, 2014
Company News

Biogen Idec Inc, Swedish Orphan Biovitrum deal

...between Swedish Orphan and Biogen Idec was between Biovitrum AB and Syntonix Pharmaceuticals Inc. Biogen Idec acquired Syntonix...
BioCentury | Mar 31, 2014
Clinical News

Alprolix rFIXFc regulatory update

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....
BioCentury | Mar 24, 2014
Clinical News

Alprolix rFIXFc regulatory update

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....
Items per page:
1 - 10 of 64
BioCentury | May 23, 2019
Company News

May 23 Company Quick Takes: Chiesi gains Raxone rights; plus WuXi Vaccines, a Zika first and more

...Other) Broad Institute of MIT and Harvard Chiesi Farmaceutici S.p.A. Columbia University Dynavax Technologies Corp. InBios International Inc. Regeneron Santhera Pharmaceuticals Holding AG Syntonix Pharmaceuticals Inc. TransCelerate...
BioCentury | Mar 7, 2016
Clinical News

Alprolix eftrenonacog alfa regulatory update

...BioCentury, Aug. 10, 2015). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
BioCentury | Sep 7, 2015
Clinical News

Long Acting rFactor lX: Interim Phase III data

...see BioCentury, Aug. 10). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
BioCentury | Aug 10, 2015
Company News

Syntonix, Biovitrum deal

...see BioCentury, June 29). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
...in 2007, and Biovitrum acquired Swedish Orphan International AB in 2009 and changed its name. Syntonix Pharmaceuticals Inc....
BioCentury | Dec 8, 2014
Company News

Syntonix, Biovitrum deal

...Nov. 10, 2014). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen Idec acquired Syntonix...
...in 2007, and Biovitrum acquired Swedish Orphan International AB in 2009 and changed its name. Syntonix Pharmaceuticals Inc....
BioCentury | Oct 20, 2014
Company News

Syntonix, Biovitrum deal

...between Swedish Orphan and Biogen Idec was between Biovitrum AB and Syntonix Pharmaceuticals Inc. Biogen Idec acquired Syntonix...
...products using XTEN to treat hemophilia (see BioCentury, April 18, 2011 & April 28, 2014). Syntonix Pharmaceuticals Inc....
BioCentury | Jul 28, 2014
Clinical News

Long Acting rFactor lX regulatory update

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....
BioCentury | Jul 14, 2014
Company News

Biogen Idec Inc, Swedish Orphan Biovitrum deal

...between Swedish Orphan and Biogen Idec was between Biovitrum AB and Syntonix Pharmaceuticals Inc. Biogen Idec acquired Syntonix...
BioCentury | Mar 31, 2014
Clinical News

Alprolix rFIXFc regulatory update

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....
BioCentury | Mar 24, 2014
Clinical News

Alprolix rFIXFc regulatory update

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....
Items per page:
1 - 10 of 64